+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Bowel Management Systems Market, by Product, by End Use, by Patient Category, by Country, Industry Analysis and Forecast, 2019 - 2025

  • PDF Icon

    Report

  • 81 Pages
  • March 2020
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5017726
The Latin America, Middle East and Africa Bowel Management System Market is expected to witness market growth of 4.4% CAGR during the forecast period (2019-2025).

The key factors driving the growth of the bowel management systems market include increased availability of advanced technological tools for fecal control, the increase in geriatric population, and the rise in fecal inconsistency related disorders. In addition, a growing awareness of the availability of these products followed by the introduction of new products addressing the many unmet needs leads to the growth of the demand for bowel management systems.

Nonetheless, a lack of qualified professionals and the discomfort of patients when using such tools hinder the market growth. On the contrary, healthcare technology R&D facilities are expected to generate lucrative prospects for the bowel management systems market. In addition, the advancement of the healthcare sector and the rise in R&D activities of key players are expected to fuel market growth over the forecast period.

Management of the neurogenic bladder and intestines includes treatment options that can help control when a patient urinates or has a bowel movement. Sometimes, a spinal cord injury prevents communication in the spinal cord between the brain and the nerves that regulate the functioning of the bladder and the bowel. This can cause inflammation of the bladder and bowels known as neurogenic bladder or neurogenic bowel. People with multiple sclerosis or may have related problems with spina bifida. Neurogenic bladder signs and symptoms can include loss of bladder control, bladder emptying failure, urinary frequency, and urinary tract infections. Neurogenic bowel symptoms include bowel loss control, constipation, bowel frequency and lack of bowel movements.

Based on Product, the market is segmented into Irrigation Systems, Colostomy Bags, Nerve Modulation Devices and Other Products. Based on End Use, the market is segmented into Home Care and Hospitals and Ambulatory Surgery Centers. Based on Patient Category, the market is segmented into Pediatric and Adult. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Coloplast Group, 3M Company, Medtronic PLC, B. Braun Melsungen AG, Becton, Dickinson and Company, Axonics Modulation Technologies, Inc., ConvaTec Group PLC, Wellspect Healthcare AB (Dentsply Sirona), Consure Medical, and Prosys International Ltd.

Scope of the Study

Market Segmentation:

By Product
  • Irrigation Systems
  • Colostomy Bags
  • Nerve Modulation Devices
  • Other Products

By End Use
  • Home Care
  • Hospitals and Ambulatory Surgery Centers

By Patient Category
  • Pediatric
  • Adult

By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled
  • Coloplast Group
  • 3M Company
  • Medtronic PLC
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Axonics Modulation Technologies, Inc.
  • ConvaTec Group PLC
  • Wellspect Healthcare AB (Dentsply Sirona)
  • Consure Medical
  • Prosys International Ltd.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Bowel Management Systems Market, by Product
1.4.2 LAMEA Bowel Management Systems Market, by End Use
1.4.3 LAMEA Bowel Management Systems Market, by Patient Category
1.4.4 LAMEA Bowel Management Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Bowel Management Systems Market by Product
3.1 LAMEA Irrigation Systems Market by Country
3.2 LAMEA Colostomy Bags Market by Country
3.3 LAMEA Nerve Modulation Devices Market by Country
3.4 LAMEA Other Products Market by Country
Chapter 4. LAMEA Bowel Management Systems Market by End Use
4.1 LAMEA Home Care Market by Country
4.2 LAMEA Hospitals and Ambulatory Surgery Centers Market by Country
Chapter 5. LAMEA Bowel Management Systems Market by Patient Category
5.1 LAMEA Pediatric Market by Country
5.2 LAMEA Adult Market by Country
Chapter 6. LAMEA Bowel Management Systems Market by Country
6.1 Brazil Bowel Management Systems Market
6.1.1 Brazil Bowel Management Systems Market by Product
6.1.2 Brazil Bowel Management Systems Market by End Use
6.1.3 Brazil Bowel Management Systems Market by Patient Category
6.2 Argentina Bowel Management Systems Market
6.2.1 Argentina Bowel Management Systems Market by Product
6.2.2 Argentina Bowel Management Systems Market by End Use
6.2.3 Argentina Bowel Management Systems Market by Patient Category
6.3 UAE Bowel Management Systems Market
6.3.1 UAE Bowel Management Systems Market by Product
6.3.2 UAE Bowel Management Systems Market by End Use
6.3.3 UAE Bowel Management Systems Market by Patient Category
6.4 Saudi Arabia Bowel Management Systems Market
6.4.1 Saudi Arabia Bowel Management Systems Market by Product
6.4.2 Saudi Arabia Bowel Management Systems Market by End Use
6.4.3 Saudi Arabia Bowel Management Systems Market by Patient Category
6.5 South Africa Bowel Management Systems Market
6.5.1 South Africa Bowel Management Systems Market by Product
6.5.2 South Africa Bowel Management Systems Market by End Use
6.5.3 South Africa Bowel Management Systems Market by Patient Category
6.6 Nigeria Bowel Management Systems Market
6.6.1 Nigeria Bowel Management Systems Market by Product
6.6.2 Nigeria Bowel Management Systems Market by End Use
6.6.3 Nigeria Bowel Management Systems Market by Patient Category
6.7 Rest of LAMEA Bowel Management Systems Market
6.7.1 Rest of LAMEA Bowel Management Systems Market by Product
6.7.2 Rest of LAMEA Bowel Management Systems Market by End Use
6.7.3 Rest of LAMEA Bowel Management Systems Market by Patient Category
Chapter 7. Company Profiles
7.1 Coloplast Group
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 3M Company
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.4 B. Braun Melsungen AG
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Becton, Dickinson and Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Axonics Modulation Technologies, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Approvals:
7.7 ConvaTec Group PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches:
7.7.5.2 Acquisition and Mergers:
7.8 Wellspect Healthcare AB (Dentsply Sirona)
7.8.1 Company Overview
7.9 Consure Medical
7.9.1 Company Overview
7.1 ProSys International Ltd.
7.10.1 Company Overview

Companies Mentioned

  • Coloplast Group
  • 3M Company
  • Medtronic PLC
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Axonics Modulation Technologies, Inc.
  • ConvaTec Group PLC
  • Wellspect Healthcare AB (Dentsply Sirona)
  • Consure Medical
  • Prosys International Ltd.

Methodology

Loading
LOADING...